Skip to main content

and
  1. No Access

    Article

    Genetic polymorphisms associated with outcome in multiple myeloma patients receiving high-dose melphalan

    High-dose melphalan (HDM) is an essential component in the treatment of patients with multiple myeloma (MM). Few data are available regarding genetic polymorphisms associated with patient outcome or toxicity i...

    C Dumontet, S Landi, T Reiman, T Perry, A Plesa, I Bellini in Bone Marrow Transplantation (2010)